Omitting bolus 5-fluorouracil (5-FU) from combination chemotherapy for gastrointestinal (GI) cancers did not adversely affect survival and was associated with less toxicity, a review of a large ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Administration of 5-FU bolus did not affect survival for ...
The FDA has approved the first smartphone application capable of initiating insulin delivery for insulin pump wearers, according to a company press release. Tandem Diabetes Care has received clearance ...
The first product in the new ruminant bolus range, Tracesure® Advanced Cattle, has officially launched with availability through an extensive network of distributors across the UK. Tracesure® Advanced ...
Protein and carbohydrate–based insulin dosing doesn't improve glycemic control compared with carbohydrate-based dosing alone in people with type 1 diabetes (T1D). Postprandial glycemic control in ...
BECAM: A salvage protocol with bevacizumab, capecitabin, and mitomycin C for patients with refractory metastatic colorectal cancer (CRC) or gastric cancer (GC) No significant financial relationships ...
A total of 539 patients were admitted to the Royal Adelaide Hospital with FBI over 15 years, with 315 patients under the Department of Gastroenterology and 224 patients under the Department of ENT.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback